Effectiveness of chronic hepatitis C treatment with direct-acting antivirals in the Public Health System in Brazil

The treatment of chronic hepatitis C virus infection for genotypes 1, 2 or 3 with the therapeutic regimens established by the Brazilian guidelines showed high rates of SVR, even in cirrhotic patients.